Report

Global In Vitro Toxicity Testing Market Size study by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. In Vitro Toxicity Testing Market, by Region, 2019-2027 (USD Billion)
1.2.2. In Vitro Toxicity Testing Market, by Product, 2019-2027 (USD Billion)
1.2.3. In Vitro Toxicity Testing Market, by Method, 2019-2027 (USD Billion)
1.2.4. In Vitro Toxicity Testing Market, by Toxicity Endpoint & Test, 2019-2027 (USD Billion)
1.2.5. In Vitro Toxicity Testing Market, by Industry, 2019-2027 (USD Billion)
1.2.6. In Vitro Toxicity Testing Market, by Technology, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global In Vitro Toxicity Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global In Vitro Toxicity Testing Market Dynamics
3.1. In Vitro Toxicity Testing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Opposition to animal testing
3.1.1.2. Increasing R&D expenditure to detect toxicity
3.1.2. Market Challenges
3.1.2.1. Lack of skilled Professionals
3.1.3. Market Opportunities
3.1.3.1. Increasing focus on drug discovery
Chapter 4. Global In Vitro Toxicity Testing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global In Vitro Toxicity Testing Market, by Product
5.1. Market Snapshot
5.2. Global In Vitro Toxicity Testing Market by Product, Performance - Potential Analysis
5.3. Global In Vitro Toxicity Testing Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4. In Vitro Toxicity Testing Market, Sub Segment Analysis

5.4.1. Consumables
5.4.2. Assays
5.4.3. Equipment
5.4.4. Software
5.4.5. Services
Chapter 6. Global In Vitro Toxicity Testing Market, by Method
6.1. Market Snapshot
6.2. Global In Vitro Toxicity Testing Market by Method, Performance - Potential Analysis
6.3. Global In Vitro Toxicity Testing Market Estimates & Forecasts by Method 2018-2027 (USD Billion)
6.4. In Vitro Toxicity Testing Market, Sub Segment Analysis
6.4.1. Cellular Assays
6.4.2. Biochemical Assays
6.4.3. In Silico Models
6.4.4. Ex Vivo Models
Chapter 7. Global In Vitro Toxicity Testing Market, by Toxicity Endpoint & Test
7.1. Market Snapshot
7.2. Global In Vitro Toxicity Testing Market by Toxicity Endpoint & Test, Performance - Potential Analysis
7.3. Global In Vitro Toxicity Testing Market Estimates & Forecasts by Toxicity Endpoint & Test 2018-2027 (USD Billion)
7.4. In Vitro Toxicity Testing Market, Sub Segment Analysis
7.4.1. ADME
7.4.2. Skin Irritation, Corrosion, & Sensitization
7.4.3. Genotoxicity Testing
7.4.4. Cytotoxicity Testing
7.4.5. Ocular Toxicity
7.4.6. Organ Toxicity
7.4.7. Phototoxicity Testing
7.4.8. Dermal Toxicity
7.4.9. Other Toxicity Endpoints & Tests
Chapter 8. Global In Vitro Toxicity Testing Market, by Industry
8.1. Market Snapshot
8.2. Global In Vitro Toxicity Testing Market by Industry, Performance - Potential Analysis
8.3. Global In Vitro Toxicity Testing Market Estimates & Forecasts by Industry 2018-2027 (USD Billion)
8.4. In Vitro Toxicity Testing Market, Sub Segment Analysis
8.5. Pharmaceuticals & Biopharmaceuticals
8.6. Cosmetic & Household Products
8.7. Food
8.8. Chemicals
Chapter 9. Global In Vitro Toxicity Testing Market, by Technology
9.1. Market Snapshot
9.2. Global In Vitro Toxicity Testing Market by Technology, Performance - Potential Analysis
9.3. Global In Vitro Toxicity Testing Market Estimates & Forecasts by Technology 2018-2027 (USD Billion)
9.4. In Vitro Toxicity Testing Market, Sub Segment Analysis
9.5. Cell Culture Technologies
9.6. High-throughput Technologies
9.7. Toxicogenomics

Chapter 10. Global In Vitro Toxicity Testing Market, Regional Analysis
10.1. In Vitro Toxicity Testing Market, Regional Market Snapshot
10.2. North America In Vitro Toxicity Testing Market
10.2.1. U.S. In Vitro Toxicity Testing Market
10.2.1.1. Product breakdown estimates & forecasts, 2018-2027
10.2.1.2. Method breakdown estimates & forecasts, 2018-2027
10.2.1.3. Toxicity Endpoint & Test breakdown estimates & forecasts, 2018-2027
10.2.1.4. Industry breakdown estimates & forecasts, 2018-2027

10.2.2. Canada In Vitro Toxicity Testing Market
10.3. Europe In Vitro Toxicity Testing Market Snapshot
10.3.1. U.K. In Vitro Toxicity Testing Market
10.3.2. Germany In Vitro Toxicity Testing Market
10.3.3. France In Vitro Toxicity Testing Market
10.3.4. Spain In Vitro Toxicity Testing Market
10.3.5. Italy In Vitro Toxicity Testing Market
10.3.6. Rest of Europe In Vitro Toxicity Testing Market
10.4. Asia-Pacific In Vitro Toxicity Testing Market Snapshot
10.4.1. China In Vitro Toxicity Testing Market
10.4.2. India In Vitro Toxicity Testing Market
10.4.3. Japan In Vitro Toxicity Testing Market
10.4.4. Australia In Vitro Toxicity Testing Market
10.4.5. South Korea In Vitro Toxicity Testing Market
10.4.6. Rest of Asia Pacific In Vitro Toxicity Testing Market
10.5. Latin America In Vitro Toxicity Testing Market Snapshot
10.5.1. Brazil In Vitro Toxicity Testing Market
10.5.2. Mexico In Vitro Toxicity Testing Market
10.6. Rest of The World In Vitro Toxicity Testing Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Merck KGaA
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Charles River
11.2.3. Bio-Rad Laboratories, Inc.
11.2.4. Abbott
11.2.5. Thermo Fisher Scientific Inc.
11.2.6. Catalent, Inc.
11.2.7. GE Healthcare
11.2.8. Quest Diagnostics Incorporated
11.2.9. Eurofins Scientific
11.2.10. Laboratory Corporation of America Holdings
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption